Elanco Requests to Dismiss Class Action Filed by Investors

Court: D. Maryland

Case: 1:24-CV-02912

Elanco has requested the court to dismiss the lawsuit filed by investors. The court will determine whether the case proceeds.

What is this lawsuit about?

On June 27, 2024, Elanco revealed delays in product approvals for Zenrelia and Credelio Quattro, with the FDA requiring a boxed warning for Zenrelia due to safety risks.

Following this, ELAN dropped over 20%.

Then, on October 7, 2024, shareholders filed a claim against Elanco.

What can you do to recover your losses now?

We’re keeping track of all updates and will notify ELAN investors about potential recovery.

More than 600 companies are currently facing securities class action lawsuits, and over 100 are already paying settlements. Connect your brokerage account to automatically check which ones you may have missed.